Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0151744 (
myocardial ischemia
)
31,282
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
During the processes of
myocardial ischemia
reperfusion (I/R) injury, inflammation and apoptosis play an important role. I/R and its induced acute myocardial infarction (AMI) with high morbidity and mortality, and there is no effective treatment for it so far.
TRAF5
has been shown to regulate inflammation and apoptosis in atherosclerosis, steatosis and melanoma cells, but its function in myocardial I/R injury is still unclear. This study demonstrates that the expression of
TRAF5
is significant up-regulation in heart tissues of I/R injury mice and hypoxia/reoxygenation (H/R)-stimulated cardiomyocytes.
TRAF5
knockout mice exhibites heavier heart damage, inflammatory response and cell death after myocardial I/R injury. Further,
TRAF5
overexpression inhibites inflammation and apoptosis of H/R-stimulated cardiomyocytes. Mechanistically, we prove that
TRAF5
promotes the activation of AKT. Overall, our study indicates that
TRAF5
can regulate the processes of myocardial I/R injury.
TRAF5
can be a new therapy target for myocardial I/R injury.
...
PMID:TRAF5 protects against myocardial ischemia reperfusion injury via AKT signaling. 3223 28